top of page

Join us to dive deep into the new Diabetes Canada Guidelines on Glycemic Management in T1D. ​ 

Learning Objectives:

​

​By the end of this program, participants will be able to:

  1. Identify practice-changing updates in the 2025 Diabetes Canada Guidelines for Glycemic Management in T1D

  2. Understand the evidence for adjunctive therapies and automated insulin delivery (AID) systems across various populations and outcomes

  3. Implement updated recommendations using practical tools to improve glycemic control and patient-reported outcomes for people with T1D

Faculty:

Dr_Ilana_Halperin_headshot1 (002).JPG

Ilana Halperin

MD, MSc, FRCPC

Toronto, ON​

Dr. Peter Senior.jpg

Peter Senior

BMedSci, MBBS, PhD, FRCP(E), FRCP

Edmonton, AB​

Ms. Alanna Chambers.jpg

Alanna Chambers

RD, CDE

Lived Experience with T1D

Kelowna, BC

Webinar Agenda (October 21, 2025):​​​​​​​​​​​​​​​​​​​​​​​​​

Screenshot 2025-10-01 093625.png

Sponsors:​​

PLATINUM:

GOLD:

SILVER PLUS:

SILVER:

Lilly-Logo.svg.png
Logo_Sanofi_(2022).png

BRONZE PLUS:

TandemHorizontalLogoNewRGBcrop-1024x283.png

BRONZE:

Novo Nordisk.webp
Abbott_Laboratories_logo.svg.png

This program is recognized by

Diabetes_Canada_logo.svg.png
DC-25-T1D-roadshow-footer-1200px.png
bottom of page